MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/15266028211067726

Медицинская библиотека · Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2022

Stents With Torsional Strength for Superficial Femoral Artery Disease: The Prospective Q3-Registry.

Thieme Marcus, Arjumand Jarwed, Spanagel Markus, Tepe Gunnar, Blessing Erwin, Kroeg Bernd, Reichert Viktor, Betge Stefan, Wickenhöfer Ralph, Teßarek Jörg, Ingwersen Maja, Krankenberg Hans

Многоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: This postmarketing surveillance study aimed to assess effectiveness and safety of a peripheral self-expanding stent with high torsional strength (POLARIS stent) for the treatment of de novo superficial femoral artery (SFA) lesions in the routine clinical practice.

MATERIALS AND

METHODS

Consecutive patients with symptomatic de novo SFA occlusive disease who underwent POLARIS stent implantation were enrolled into the prospective, multicenter, observational postmarket surveillance study. Primary outcome measure was freedom from clinically driven target lesion revascularization (cdTLR) at 12 months. Main secondary outcomes were procedural success, primary clinical improvement, and freedom from major adverse cardiovascular and limb events (MACLE) throughout 24 months.

RESULTS

A total of 199 participants (70±11 years, 70.4% men) were included in the study at 9 German sites from December 2014 to August 2018. Half of them (52.6%) were current smokers, 37.6% had diabetes, and 25.0% were obese. Most participants suffered from intermittent claudication (88.4%). Mean lesion length was 98±83 mm, 43.5% of lesions were occluded, and 27.3% were severely calcified. Freedom from 12 months cdTLR was 94.4% (95% confidence interval [CI], 90.6-98.2). At 24 months, freedom from cdTLR was 88.7% (95% CI, 83.0-94.4). Procedural success was achieved in 96.2% of participants. Primary clinical improvement occurred in 87.5% and 85.4% of participants at 12 and 24 months, respectively. Freedom from MACLE was 94.8% (95% CI, 91.4-98.1) and 93.8% (95% CI, 89.9-97.6) at 12 and 24 months, respectively.

CONCLUSIONS

Treatment of SFA occlusive disease in a real-world setting using the POLARIS stent with high bidirectional torsional strength is efficacious and does not raise any safety concern in the medium term. The study is registered with ClinicalTrials.gov (Identifier: NCT02307292).

Для цитирования: Thieme Marcus, Arjumand Jarwed, Spanagel Markus, Tepe Gunnar, Blessing Erwin, Kroeg Bernd, Reichert Viktor, Betge Stefan, Wickenhöfer Ralph, Teßarek Jörg, Ingwersen Maja, Krankenberg Hans. Stents With Torsional Strength for Superficial Femoral Artery Disease: The Prospective Q3-Registry.. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2022. DOI: 10.1177/15266028211067726.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.